Low risk of fractures in long-term treatment of Paget's disease with tiludronate.

Audran, M., Combe, B., Michaut, S., Devogelaer, J.-P., Dricot, J., & Reginster, J. (1996). Low risk of fractures in long-term treatment of Paget’s disease with tiludronate. Journal of Bone and Mineral Research, 11, M764-M764. (Original work published 1996)